January 30, 2025 - 04:36

FORT WAYNE, Ind., January 29, 2025—Saint Roch Veterinary LLC has announced the launch of GingiGuard™, a groundbreaking, patented treatment specifically designed to combat canine periodontitis. This innovative product promises sustained plaque suppression, addressing a significant health issue in dogs that often goes unnoticed by pet owners.
Periodontal disease is one of the most common health problems affecting dogs, leading to pain, tooth loss, and even systemic health issues if left untreated. GingiGuard™ aims to change the landscape of canine dental care by providing a proactive solution that not only treats existing conditions but also helps prevent future plaque buildup.
The development of GingiGuard™ involved extensive research and collaboration among veterinary professionals, ensuring a safe and effective option for dogs of all breeds and sizes. The veterinary community is optimistic about the potential impact of this treatment, as it could significantly improve the quality of life for countless pets and ease the burden on their owners. As the product rolls out, Saint Roch Veterinary LLC is committed to educating pet owners about the importance of dental health in their furry companions.
October 21, 2026 - 20:59
Sea Buckthorn and Respiratory Health: What Pharmacists Need to KnowSea buckthorn is a commonly used herbal for respiratory health, and US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season. Sea buckthorn, known...
October 21, 2026 - 05:08
How You Drink Your Tea May Affect Heart Health, Study FindsThe way you prepare and drink your tea could influence your cardiovascular health, according to a new study. Researchers found that tea itself offers meaningful benefits for the heart, but those...
October 20, 2026 - 23:59
Maryland Expands Reproductive Health Training Program With State FundingThe University of Maryland is broadening a reproductive health initiative with more than $16 million in state grant funds spread across five years. The investment builds on earlier work that has...
October 20, 2026 - 13:46
GLP-1 Drugs Tied to Better Kidney Outcomes in Bipolar Disorder PatientsResearchers have found that GLP-1 receptor agonists, a class of medications commonly prescribed for diabetes and weight management, may offer significant protection for kidney health in adults...